Log in
0 followers
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Stage
Employees
Links
Scott Clarke
11 members
4 members
3 members
1 members
Red Hat
126 followers
Abbott
198 followers
Comscore
16 followers
Snowflake
278 followers
Intercom
94 followers
Discover companies